• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy 
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Preventive Neurology Unit
    • Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Preventive Neurology Unit
    • Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy

    Volume
    27
    Pagination
    775 - 776
    Journal
    MULTIPLE SCLEROSIS JOURNAL
    Issue
    2_SUPPL
    ISSN
    1352-4585
    Metadata
    Show full item record
    Authors
    Vickaryous, N; Asardag, AN; Chance, R; Jones, M; Bestwick, J; Shah, SN; George, K; Schmierer, K; Giovannoni, G; Baker, D
    URI
    https://qmro.qmul.ac.uk/xmlui/handle/123456789/75630
    Collections
    • Preventive Neurology Unit [101]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.